Literature DB >> 10548135

Physical and psychological consequences of weight gain.

I Kawachi1.   

Abstract

Obesity and overweight are clearly associated with many serious conditions, including type II diabetes mellitus, hypertension, and coronary heart disease. Excess weight also increases the risk of death. Recent evidence suggests that weight gain itself, even if persons remain within the "normal" weight range, also increases the risk of medical illnesses and premature death. Persons who gain 5.0 to 7.9 kg (11 to 17.3 lb) as adults are 1.9 times more likely to develop type II diabetes mellitus and 1.25 times more likely to develop coronary heart disease than those who lose weight or maintain a stable weight after age 18 years. Gaining 11 to 20 kg (24.2 to 44 lb) or more in adulthood increases the risk of ischemic stroke 1.69 to 2.52 times. The relationship between weight gain and breast cancer has been difficult to study, primarily because postmenopausal hormone replacement therapy can mask the effect of weight gain on cancer risk. Accordingly, weight gain in adulthood has been associated with an increased risk of breast cancer only among women who have never used hormone replacement therapy. In addition to its adverse effects on disease outcomes, weight gain also impairs physical functioning, reduces quality of life, and is associated with poor mental health. These psychological and mental health consequences of weight gain can become an added burden for patients with schizophrenia and other mental disorders.

Entities:  

Mesh:

Year:  1999        PMID: 10548135

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  17 in total

1.  Are African American patients at a higher risk for olanzapine-induced glucose intolerance?

Authors:  J Ananth; S Gunatilake; S Aquino; V Bach; J Costa
Journal:  Psychopharmacology (Berl)       Date:  2001-09       Impact factor: 4.530

2.  The Scandinavian Solutions for Wellness study - a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disorders.

Authors:  Vibeke Porsdal; Catherine Beal; Ole Kristian Kleivenes; Egil W Martinsen; Eva Lindström; Harriet Nilsson; Pär Svanborg
Journal:  BMC Psychiatry       Date:  2010-06-10       Impact factor: 3.630

Review 3.  Pharmacogenetics of antipsychotic-induced weight gain.

Authors:  Christoph U Correll; Anil K Malhotra
Journal:  Psychopharmacology (Berl)       Date:  2004-07-08       Impact factor: 4.530

4.  Dietary intake of patients with schizophrenia.

Authors:  Martin Strassnig; Jaspreet Singh Brar; Rohan Ganguli
Journal:  Psychiatry (Edgmont)       Date:  2005-02

5.  Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment.

Authors:  Ashley Tsai; Ying-Jay Liou; Chen-Jee Hong; Chia-Liang Wu; Shih-Jen Tsai; Ya Mei Bai
Journal:  Neuromolecular Med       Date:  2011-09-29       Impact factor: 3.843

Review 6.  Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications.

Authors:  J M Russell; J A Mackell
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

7.  Sleep Disturbance in Bipolar Disorder Across the Lifespan.

Authors:  Allison G Harvey; Lisa S Talbot; Anda Gershon
Journal:  Clin Psychol (New York)       Date:  2009-06

8.  Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study.

Authors:  P Aro; J Ronkainen; N J Talley; T Storskrubb; E Bolling-Sternevald; L Agréus
Journal:  Gut       Date:  2005-05-25       Impact factor: 23.059

9.  Efficacy and tolerability of an herbal formulation for weight management.

Authors:  Judith S Stern; Jan Peerson; Artatrana T Mishra; Venkata Sadasiva Rao Mathukumalli; Poorna Rajeswari Konda
Journal:  J Med Food       Date:  2013-06       Impact factor: 2.786

Review 10.  Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.

Authors:  Kimberly A Stigler; Marc N Potenza; David J Posey; Christopher J McDougle
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.